Evidence map›Paper›PMID 30050865›Full record

ReviewVeterinary medicine (Auckland, N.Z.)2018

Managing feline diabetes: current perspectives.

Susan Gottlieb, Jacquie Rand

Open access · goldAbstract readReview
In one paragraph

Review in Veterinary medicine (Auckland, N.Z.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. SGLT2 inhibitor use in the management of feline diabetes mellitus.Journal of veterinary pharmacology and therapeutics · 2025
    Review
  8. Article
  9. Diabetes Technology and Pets: A Market of the Future?Journal of diabetes science and technology · 2024
    Article
  10. Article
  11. Survival, remission, and quality of life in diabetic cats.Journal of veterinary internal medicine · 2023
    Article
  12. Article
  13. Changes in glucose tolerance and insulin secretion in a cohort of cats with chronic obesity.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Susan GottliebThe Cat Clinic, Brisbane, QLD, Australia, susanalisongottlieb@gmail.com.
Jacquie RandSchool of Veterinary Science, The University of Queensland, Gatton, QLD, Australia, susanalisongottlieb@gmail.com.
University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is a common endocrine disease in cats. While type 2 diabetes is the most common form seen in cats, other underlying causes may contribute to insulin resistance. Guidelines for diagnosis vary and often do not take into account prediabetic cats. The goals of treatment are to maximize the chance of remission, while minimizing the risks of hypoglycemia. This article presents a further overview of current treatment and monitoring recommendations for diabetic cats.

Indexed as

catsdiabetes mellitusdiabetic remissionfelinegluconeogenesisglucose tolerance

Identifiers

PMID30050865
PMCPMC6053045
OpenAlexW2808280656

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.